"The Neglected Battle: Addressing the Needs of Those with Rare and Deadly Cancers"
Glioblastoma (GBM) is a rare and deadly brain tumor with limited treatment options, leading to a low survival rate. The lack of urgency and funding in developing new treatments for GBM has resulted in minimal progress, hindering the chances of survival for patients. The exorbitant cost of developing new approaches, inadequate funding, and lengthy clinical trial timelines are major obstacles. Nonprofits like OurBrainBank are advocating for increased government funding and support to improve research and treatment options for GBM patients and their families.